Funds holding CONTRA LIGAND PHARMACE- NPV
ISIN US532CNT0118 · United States
- Fund holders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 0 $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| S&P SmallCap 600 Pure Growth Fund Rydex Variable Trust | 169 | 0 $ | as of Jun 30, 2026 ↗ | |
| S&P SmallCap 600 Pure Growth Fund Rydex Series Funds | 107 | 0 $ | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | 0 | 276 | 0.0 % |
| 2026Q2 | 2 | 276 |
Cite this page
Titelia. "Funds holding CONTRA LIGAND PHARMACE- NPV". https://titelia.com/en/stocks/contra-ligand-pharmace-npv-US532CNT0118